查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095339

疫苗輸送裝置市場－2026-2032年全球市場預測

Vaccine Delivery Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，疫苗輸送設備市場規模將達到 133.5 億美元，複合年成長率為 7.41%。

主要市場統計數據
基準年 2025 80.9億美元
預計年份：2026年 86.6億美元
預測年份 2032 133.5億美元
複合年成長率 (%) 7.41%

疫苗輸送裝置：執行摘要

隨著醫療衛生系統尋求更安全、更快、更人性化、更具韌性的疫苗接種方式，疫苗輸送裝置正成為全球免疫規劃的策略支柱。這一領域涵蓋傳統注射器和針頭、自動丟棄注射器、預填充式注射器、噴射噴射注射器、微針貼片、鼻噴劑、口服給藥系統以及支援可追溯性和依從性的連網型設備。需求受兒童常規免疫、成人免疫、感染疾病應對、旅行者健康、職業健康以及呼吸道疾病、腫瘤和新發感染疾病疫苗接種範圍擴大等因素的影響。公共衛生領域的檢驗證據表明，接種方式會影響疫苗接種率、劑量浪費、接種安全性、低溫運輸表現、訓練需求、銳器廢棄物以及使用者接受度。隨著各國政府加強免疫公平性、生命全程免疫和疫情防範，疫苗輸送裝置正從單純的採購項目轉變為保障疫苗可及性、依從性和營運效率的綜合基礎。

一項變革性的變革，重新設計了疫苗輸送裝置。

疫苗接種器材領域正經歷結構性變革，從傳統的院內針頭注射器接種模式轉向多元化、人性化、數位化驅動的接種模式。自動失效注射器透過降低重複使用風險，持續在公共免疫接種計畫中發揮核心作用，保障疫苗安全。預填充和即用型疫苗在速度、劑量準確性、減少配製錯誤和降低污染風險至關重要的場合中日益受到重視。無針注射器、微針貼片、鼻噴劑和口服疫苗途徑也日益受到關注，因為它們可以減輕人們對針頭的恐懼，簡化接種流程，並支持在學校、藥房、社區宣傳活動、急診室和資源匱乏的環境中更廣泛地分發疫苗。監管機構對器械的品質、無菌性、人體工學、可用性檢驗以及複合產品的性能也提出了更高的要求。同時，疫情帶來的限制暴露了對注射器、玻璃、塑膠、彈性體、塞子、包裝、消毒能力和低溫運輸物流的依賴性，使得供應鏈韌性成為重中之重。因此，醫療設備創新、在地化生產、全生命週期永續性、改進的採購體係以及與免疫資訊系統的整合正日益成為新的發展趨勢。

人工智慧對疫苗輸送裝置的累積影響

人工智慧 (AI) 正逐步影響疫苗輸送裝置的方方面面，從設計製造到分發、接種和使用後監測。在產品開發方面，AI 驅動的建模可以透過識別測試數據、模擬使用場景和人體工學輸入資訊中的模式，改進裝置的人體工學、劑量一致性、材料選擇、設計檢驗和失效模式分析。在製造方面，機器視覺、自動化檢測、統計製程控制和預測性維護可以增強對關鍵部件（例如針頭、活塞、氣缸、密封件、噴霧機構、安全防護罩和微針陣列）的品管。在免疫接種工作中，尤其是在大規模宣傳活動和感染疾病應變中，AI 可以改善需求規劃、路線最佳化、低溫運輸監控、庫存分配、接種計畫安排和減少浪費。互聯的輸送系統和數位健康平台可以輔助身份驗證、病患提醒、不利事件預警、批次級文件記錄和疫苗接種檢驗。然而，其應用需要檢驗的演算法、網路安全、互通性、隱私保護、減少偏差和明確的監管規定。人工智慧的累積影響不僅限於自動化，還能建構一個更可靠、可追溯、更具適應性的疫苗接種生態系統。

關於疫苗輸送裝置部署的關鍵區域見解

亞太地區的特點是：大規模公共免疫接種計畫、不斷擴大的國內製造業，以及高所得國家、新興經濟體、島嶼國家和偏遠地區多樣化的「最後一公里」配送需求。該地區各國優先考慮恢復常規免疫接種、做好應對疫情的準備，以及本地生產注射器和相關耗材。同時，人們對微針貼片、鼻腔給藥和耐熱製劑的興趣日益濃厚，反映出向農村、山區和島嶼人口提供疫苗的必要性。歐洲的特點是對醫療設備和複雜產品實施嚴格的監管，高度重視病人安全、永續性、藥物安全監測以及老齡化社會的疫苗接種，所有這些都支持對高品質、安全且環保的給藥系統的需求。北美的優點在於：擁有先進的監管基礎設施、健全的藥房免疫接種管道、數位免疫接種登記系統，並率先採用預填充、安全且連網的給藥方式，尤其是在成人、季節性、旅客和感染疾病相關疫苗接種方面。在拉丁美洲，由於各國免疫規劃致力於解決疫苗接種差異、跨境疾病風險、採購連續性以及都市區、農村和偏遠社區的低溫運輸限制等問題，因此對可靠、價格合理且宣傳活動使用的醫療設備的需求持續存在。非洲仍然是疫苗供應創新至關重要的地區，因為免疫接種的成功與疫苗的價格可承受性、自去活化注射器的可用性、社區參與、低溫運輸可靠性、銳器廢棄物管理以及能夠減少對高技能人員和複雜物流依賴的供應技術密切相關。在中東，醫療衛生系統的現代化、國家免疫制度的發展以及對低溫運輸基礎設施的投資正在穩步推進。海灣國家正在推動數位醫療的整合和集中採購，而其他市場則專注於改善醫療服務可近性、增強緊急準備能力和提高採購可靠性。

疫苗輸送裝置策略的關鍵小組見解

儘管北約成員國並非醫療保健市場集團，但它們日益重視生物安全、軍事戰備、緊急儲備和快速疫苗接種能力，這促使人們對適用於民用和國防戰備的、堅固耐用、易於部署、可追溯且方便用戶使用的疫苗輸送裝置產生濃厚興趣。七國集團（G7）與先進的生物醫學研究、疫情應對資金、成熟的監管體系、藥物安全監測機制以及對下一代給藥途徑（包括無針、鼻腔和貼片技術）的早期評估緊密相關。金磚國家（BRICS）擁有龐大的人口、自主生產的意願以及不斷完善的公共衛生基礎設施，對價格合理的注射器、本地生產的裝置、可低溫運輸運輸的裝置以及能夠提高疫苗宣傳活動效率的新平台的推廣具有重要影響。歐盟（EU）強調監管協調、安全性、永續性、資料保護以及醫療設備的跨境可用性，因此對於滿足嚴格的品質、人體工學、環境和可追溯性要求的輸送裝置至關重要。東協的免疫接種格局高度多樣化，人口稠密的都市區與島嶼地區、邊境地區和農村地區並存。這些地區需要高度便攜、低廢棄物、價格合理且易於操作的疫苗接種設備。海灣合作理事會（GCC）的特點是醫療衛生領域的大量投資、數位轉型以及集中採購模式，這些因素正在推動安全可追溯的疫苗接種系統的引入，尤其是在季節性、旅行者、兒童、成人和緊急免疫接種計畫中。

各國疫苗輸送裝置部署情況的關鍵訊息

中國擁有大規模的免疫接種能力、不斷擴展的醫療設備製造能力、完善的數位醫療基礎設施以及強大的公共衛生合作體系，為高度擴充性的疫苗遞送技術和可追溯的給藥模式提供了有力支持。美國在藥房免疫接種、成人免疫接種基礎設施、先進的醫療設備法規、以安全為中心的注射技術以及高度互聯、以患者為中心的疫苗遞送模式的評估方面處於世界領先地位。日本在其老齡化社會中，優先考慮疫苗的品質、準確性、安全性、易用性和可接受性，尤其重視預填充、低誤差和以病人為中心的給藥系統。印度擁有全民免疫接種計劃、大規模的出生人口、廣泛的公共衛生網路和國內生產能力，是擴充性、經濟高效且可現場使用的疫苗供應技術的關鍵樞紐。德國、英國、法國、義大利和西班牙的特點是老齡化社會、季節性呼吸道疾病疫苗接種、對安全性的高期望、成熟的法規環境以及日益重要的藥房和社區免疫接種模式。澳洲注重為分散居住的人口提供疫苗接種服務，推行以藥房為基礎的免疫接種模式，確保可靠的低溫運輸供應，支持原住民和偏遠社區，並做好應對當地健康威脅的準備。同時，韓國結合先進的製造技術、數位基礎設施和強大的公共衛生夥伴關係，致力於生產高品質、可追溯且高效的疫苗接種設備。加拿大優先考慮各省、地區和偏遠社區的公平獲取，因此對可靠、低溫運輸的設備和簡化的接種方法有著迫切的需求。俄羅斯優先發展國內生產，並致力於滿足其廣大領土上廣泛的公共免疫接種需求，因此供應的韌性、分銷效率和持久的供應鏈至關重要。巴西和墨西哥依靠以可負擔性、供應連續性和宣傳活動效率為大規模國家免疫規劃，巴西也進一步維護強大的公共衛生部門生產和免疫接種基礎設施，以支持疫苗的廣泛普及。

為疫苗接種設備領導企業提供的實用建議

行業領導企業應優先設計能夠提高安全性、易用性、劑量準確性和患者接受度的設備，同時減少培訓負擔、針刺傷風險、簡化配製流程並降低給藥錯誤。投資應集中於可擴展的平台，這些平台需符合疫苗穩定性、監管要求、採購標準和現場給藥環境，包括自動去活化注射器、預填充系統、安全設計注射器、鼻腔給藥裝置、噴射注射器、口服製劑和微針技術。製造商應透過採購管道多元化、檢驗的二級供應商、區域生產夥伴關係、滅菌能力規劃以及健全的無菌組件品質系統來增強供應韌性。數位化整合應透過可互通的資料標準、設備可追溯性、低溫運輸可視性、安全認證以及與免疫登記系統的整合來實現。永續性應從單純的目標發展成為產品策略，在不影響無菌性和安全性的前提下，解決材料選擇、包裝減少、銳器廢棄物處理、回收途徑和生命週期影響等問題。領導者還應投資於人因工程研究、醫護人員培訓工具、上市後證據以及部署數據，以證明疫苗接種率的提高、廢棄物的減少、工作流程的簡化、公平性的提升以及用戶體驗的改善。商業性成功取決於創新能否與公共採購、監管合規、可負擔性和疫苗接種計劃的營運限制等實際情況相契合。

疫苗輸送裝置分析的調查方法

本執行摘要基於系統性的二手研究途徑，採用檢驗的公共衛生、監管、臨床和技術資訊來源。該調查方法著重於對全球免疫指南、醫療設備法規結構、疫苗劑量標準、同行評審文獻、公共採購實踐、疾病預防項目、低溫運輸指南、安全注射政策以及已記錄的技術趨勢進行橫斷面匹配。透過對器械類別、給藥途徑、區域免疫優先事項、供應鏈韌性因素、數位醫療應用、監管預期和新興創新路徑的定性分析，評估了相關見解。本研究避免了不實預測，因此不涉及市場規模、市場佔有率和未來預測。透過比較公共衛生基礎設施、免疫規劃成熟度、監管環境、生產能力、低溫運輸要求、取得挑戰和準備優先事項，得出區域、群體和國家層面的具體見解。最終分析著重於基於證據的疫苗輸送器材策略意義，包括安全性、易用性、擴充性、公平性、品質保證、永續性、可追溯性和營運準備。

結論：更聰明的疫苗輸送裝置可以提高疫苗的可及性。

疫苗輸送裝置不再只是用於單次注射的機械裝置；它們在免疫接種效果、公眾信心和醫療衛生系統的韌性方面發揮核心作用。下一階段的發展將以更安全的注射技術、預填充用型疫苗、無針和黏膜給藥、微針貼片、數位化可追溯性、人工智慧驅動的營運智慧以及更強大的供應鏈為特徵。儘管各地區的優先事項可能有所不同，但通用的方向是明確的：政府和醫療機構需要可靠、經濟、易於部署、對醫護人員安全、患者可接受且能適應常規和緊急免疫接種需求的輸送系統。那些兼具卓越監管、生產韌性、人性化的設計、永續性和實證數位化整合能力的機構，將更有能力支持全球免疫接種目標的實現。隨著疫苗科學的進步，輸送裝置將繼續成為創新與實際防護之間的關鍵橋樑。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：疫苗輸送裝置市場：依裝置類型分類

  • 自動噴油器
    • 一次性自動注射器
    • 可重複使用的電子自動注射器
    • 機械式可重複使用自動注射器
  • 點滴幫浦
    • 彈性體泵
    • 注射式幫浦
    • 容積式泵
      • 攜帶式容積泵
      • 落地式容積泵
  • 噴射注射器
  • 無針注射器
    • 液體注射器
    • 粉末注射器
  • 筆式注射器
    • 一次性筆式注射器
    • 可重複使用的筆式注射器
      • 電子可重複使用筆式注射器
      • 機械式可重複使用筆型注射器
  • 預填充式注射器

第8章：疫苗輸送裝置市場：依給藥途徑分類

  • 皮內注射
  • 肌肉內注射
  • 靜脈注射
  • 黏膜給藥
    • 鼻腔給藥
    • 口服
  • 皮下注射

第9章：疫苗輸送裝置市場：依技術分類

  • 傳統注射技術
  • 無針技術
  • 微針技術
  • 智慧配送技術
  • 緩釋技術
  • 熱穩定技術

第10章：疫苗輸送裝置市場：依疫苗類型分類

  • 減毒活疫苗
  • 去活化疫苗
  • 次單位疫苗
  • 藥效疫苗
  • DNA疫苗
  • 病毒載體疫苗

第11章：疫苗輸送裝置市場：依最終用戶分類

  • 門診部
  • 診所
    • 基層醫療診所
    • 專科診所
  • 家庭醫療保健
  • 醫院

第12章：疫苗輸送裝置市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第13章：疫苗輸送裝置市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第14章：疫苗輸送裝置市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • 3M Company
  • ApiJect Systems Corp.
  • AptarGroup, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Catalent, Inc.
  • Credence MedSystems, Inc.
  • Crossject SA
  • Gerresheimer AG
  • Inovio Pharmaceuticals, Inc.
  • Micron Biomedical, Inc.
  • NanoPass Technologies Ltd.
  • Nemera Development SA
  • Nipro Corporation
  • Owen Mumford Ltd.
  • PharmaJet, Inc.
  • Portal Instruments, Inc.
  • Precision NanoSystems Inc.
  • SCHOTT Pharma AG & Co. KGaA
  • SHL Medical AG
  • Smiths Group plc
  • Stevanato Group SpA
  • Terumo Corporation
  • Unilife Corporation
  • Valeritas Holdings, Inc
  • Vaxxas Pty Ltd
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding AG
Product Code: MRR-02026C4C8C99

The Vaccine Delivery Devices Market is projected to grow by USD 13.35 billion at a CAGR of 7.41% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.09 billion
Estimated Year [2026] USD 8.66 billion
Forecast Year [2032] USD 13.35 billion
CAGR (%) 7.41%

Vaccine Delivery Devices: Executive Summary

Vaccine delivery devices are becoming a strategic pillar of global immunization programs as health systems seek safer, faster, more patient-friendly, and more resilient ways to administer vaccines. The landscape includes conventional syringes and needles, auto-disable syringes, prefilled syringes, jet injectors, microneedle patches, intranasal sprayers, oral delivery systems, and connected devices that support traceability and adherence. Demand is shaped by routine childhood immunization, adult vaccination, outbreak response, travel health, occupational health, and the expansion of vaccines for respiratory, oncology, and emerging infectious disease indications. Verified public health evidence shows that delivery format influences vaccination coverage, dose wastage, administration safety, cold-chain performance, training requirements, sharps waste, and user acceptance. As governments strengthen immunization equity, life-course vaccination, and pandemic preparedness, vaccine delivery devices are moving from procurement commodities to integrated enablers of access, compliance, and operational efficiency.

Transformative Shifts Reshaping Vaccine Delivery Devices

The vaccine delivery devices landscape is undergoing a structural shift from traditional facility-based needle-and-syringe administration toward diversified, human-centered, and digitally enabled delivery models. Auto-disable syringes remain central to safe immunization in public programs because they reduce reuse risk, while prefilled and ready-to-use formats are gaining relevance where speed, dose accuracy, reduced preparation errors, and lower contamination risk are priorities. Needle-free injectors, microneedle patches, intranasal sprayers, and oral vaccine delivery routes are receiving heightened attention because they can reduce needle anxiety, simplify administration, and support broader reach in schools, pharmacies, community campaigns, emergency clinics, and resource-constrained settings. Regulatory expectations for device quality, sterility assurance, human factors engineering, usability validation, and combination product performance are also rising. At the same time, supply chain resilience has become a defining priority after pandemic-era constraints exposed dependencies in syringes, glass, plastics, elastomers, stoppers, packaging, sterilization capacity, and cold-chain logistics. The result is an environment increasingly defined by device innovation, localized production, lifecycle sustainability, procurement readiness, and integration with immunization information systems.

Cumulative Impact of Artificial Intelligence on Vaccine Delivery Devices

Artificial intelligence is beginning to influence vaccine delivery devices across design, manufacturing, distribution, administration, and post-use surveillance. In product development, AI-supported modeling can improve device ergonomics, dose-delivery consistency, material selection, design verification, and failure mode analysis by identifying patterns across test data, simulated use scenarios, and human factors inputs. In manufacturing, machine vision, automated inspection, statistical process control, and predictive maintenance can enhance quality control for critical components such as needles, plungers, barrels, seals, spray mechanisms, safety shields, and microneedle arrays. In immunization operations, AI can improve demand planning, route optimization, cold-chain monitoring, stock allocation, session planning, and wastage reduction, especially during mass campaigns or outbreak response. Connected delivery systems and digital health platforms can support authentication, patient reminders, adverse event signal detection, lot-level documentation, and verification of vaccine administration. However, adoption depends on validated algorithms, cybersecurity, interoperability, privacy safeguards, bias mitigation, and regulatory clarity. The cumulative impact of AI is not simply automation; it is the creation of more reliable, traceable, and adaptive vaccination ecosystems.

Key Regional Insights Across Vaccine Delivery Device Adoption

Asia-Pacific is characterized by large-scale public immunization programs, expanding domestic manufacturing, and diverse last-mile delivery needs across high-income, emerging, island, and remote settings. Countries in the region are prioritizing routine immunization recovery, pandemic preparedness, and localized production of syringes and related consumables, while interest in microneedle patches, intranasal delivery, and thermostability-compatible formats reflects the need to reach rural, mountainous, and archipelagic populations. Europe is shaped by stringent device and combination-product regulation, strong emphasis on patient safety, sustainability, pharmacovigilance, and vaccination across aging populations, supporting demand for high-quality, safety-engineered, and environmentally responsible delivery systems. North America benefits from advanced regulatory infrastructure, strong pharmacy-based vaccination channels, digital immunization registries, and early adoption of prefilled, safety-engineered, and connected delivery formats, particularly for adult, seasonal, travel, and outbreak-related vaccination. Latin America shows sustained need for reliable, affordable, and campaign-ready devices as national immunization programs address coverage gaps, cross-border disease risks, procurement continuity, and cold-chain constraints across urban, rural, and remote communities. Africa remains a critical region for vaccine delivery innovation because immunization success is closely linked to affordability, auto-disable syringe availability, community outreach, cold-chain reliability, sharps waste management, and delivery technologies that can reduce dependence on highly trained personnel or complex logistics. The Middle East is investing in health system modernization, national immunization readiness, and cold-chain infrastructure, with Gulf countries advancing digital health integration and centralized procurement while other markets focus on strengthening access, emergency preparedness, and procurement reliability.

Key Group Insights for Vaccine Delivery Device Strategies

NATO countries, while not a health market bloc, have heightened focus on biosecurity, military readiness, emergency stockpiles, and rapid vaccination capacity, supporting interest in rugged, deployable, traceable, and easy-to-use vaccine delivery devices for civilian and defense preparedness. G7 countries are closely associated with advanced biomedical research, pandemic preparedness funding, mature regulatory systems, pharmacovigilance capacity, and early evaluation of next-generation delivery routes, including needle-free, intranasal, and patch-based technologies. BRICS countries combine large populations, domestic manufacturing ambitions, and expanding public health infrastructure, making them influential in scaling affordable syringes, localized device production, cold-chain-compatible formats, and novel platforms that can improve campaign efficiency. The European Union emphasizes regulatory harmonization, medical device safety, sustainability, data protection, and cross-border preparedness, creating strong relevance for delivery devices that meet rigorous quality, human factors, environmental, and traceability requirements. ASEAN represents a highly varied immunization environment, where densely populated urban centers coexist with island, border, and rural communities that require portable, low-waste, affordable, and easy-to-administer vaccine delivery devices. The GCC is distinguished by high healthcare investment, digital transformation, and centralized procurement approaches that support adoption of safety-engineered and traceable delivery systems, particularly for seasonal, travel, pediatric, adult, and emergency vaccination programs.

Key Country Insights in Vaccine Delivery Device Adoption

China combines large-scale immunization capacity with expanding medical device manufacturing, digital health infrastructure, and strong public health coordination, supporting scalable vaccine delivery technologies and traceable administration models. The United States leads in pharmacy-based immunization, adult vaccination infrastructure, advanced device regulation, safety-engineered injection practices, and evaluation of connected and patient-friendly vaccine delivery formats. Japan prioritizes quality, precision, safety, usability, and acceptance among aging populations, making prefilled, low-error, and patient-centered delivery systems especially relevant. India's universal immunization program, large birth cohort, extensive public health network, and domestic production capabilities make it a major center for scalable, cost-effective, and field-ready delivery technologies. Germany, the United Kingdom, France, Italy, and Spain are shaped by aging populations, seasonal respiratory vaccination, strong safety expectations, mature regulatory environments, and increasingly important pharmacy and community-based administration models. Australia focuses on access across dispersed populations, pharmacy immunization, cold-chain reliability, Indigenous and remote community outreach, and preparedness for regional health threats, while South Korea combines advanced manufacturing, digital infrastructure, and strong public health coordination to support high-quality, traceable, and efficiency-oriented vaccine delivery devices. Canada emphasizes equitable access across provinces, territories, and remote communities, creating demand for reliable cold-chain-compatible devices and simplified administration. Russia maintains domestic production priorities and broad public immunization needs across a geographically vast territory, making supply resilience, distribution performance, and durable delivery systems important. Brazil and Mexico rely on large national immunization programs where affordability, supply continuity, and campaign efficiency are central, with Brazil also maintaining strong public health manufacturing and vaccination infrastructure to support broad vaccine access.

Actionable Recommendations for Vaccine Delivery Device Leaders

Industry leaders should prioritize device designs that improve safety, ease of use, dose accuracy, and patient acceptance while reducing training burden, needlestick injury risk, preparation steps, and administration errors. Investment should focus on scalable platforms such as auto-disable syringes, prefilled systems, safety-engineered injectors, intranasal devices, jet injectors, oral formats, and microneedle technologies where they align with vaccine stability, regulatory requirements, procurement criteria, and real-world delivery settings. Manufacturers should strengthen supply resilience through diversified sourcing, validated secondary suppliers, regional production partnerships, sterilization capacity planning, and robust quality systems for sterile components. Digital integration should be pursued through interoperable data standards, device traceability, cold-chain visibility, secure authentication, and linkage with immunization registries. Sustainability should move from aspiration to product strategy by addressing material selection, packaging reduction, sharps waste, take-back pathways, and lifecycle impacts without compromising sterility or safety. Leaders should also invest in human factors studies, health worker training tools, post-market evidence, and implementation data that demonstrate improvements in coverage, wastage reduction, workflow efficiency, equity, and user experience. Commercial success will depend on aligning innovation with public procurement realities, regulatory compliance, affordability, and the operational constraints of vaccination programs.

Research Methodology for Vaccine Delivery Device Analysis

This executive summary is based on a structured secondary research approach using verified public health, regulatory, clinical, and technology sources. The methodology emphasizes triangulation across global immunization guidance, medical device regulatory frameworks, vaccine administration standards, peer-reviewed literature, public procurement practices, disease prevention programs, cold-chain guidance, safety injection policies, and documented technology trends. Insights were assessed through qualitative analysis of device categories, delivery routes, regional immunization priorities, supply-chain resilience factors, digital health adoption, regulatory expectations, and emerging innovation pathways. The research avoids unsupported projections and excludes market sizing, market share, and forecasting. Regional, group, and country insights were developed by comparing public health infrastructure, immunization program maturity, regulatory conditions, manufacturing capabilities, cold-chain requirements, access challenges, and preparedness priorities. The final analysis focuses on evidence-backed strategic implications for vaccine delivery devices, including safety, usability, scalability, equity, quality assurance, sustainability, traceability, and operational readiness.

Conclusion: Advancing Access Through Smarter Vaccine Delivery Devices

Vaccine delivery devices are no longer limited to the mechanics of administering a dose; they are central to immunization performance, public trust, and health system resilience. The next phase of development will be shaped by safer injection technologies, prefilled and ready-to-use formats, needle-free and mucosal delivery, microneedle patches, digital traceability, AI-enabled operational intelligence, and stronger supply chain preparedness. Regional priorities vary, but the common direction is clear: governments and healthcare providers need delivery systems that are reliable, affordable, easy to deploy, safe for health workers, acceptable to patients, and adaptable to routine and emergency vaccination needs. Organizations that combine regulatory excellence, manufacturing resilience, human-centered design, sustainability, and evidence-based digital integration will be best positioned to support global immunization goals. As vaccine science advances, delivery devices will remain a decisive link between innovation and real-world protection.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Vaccine Delivery Devices Market, by Device Type

  • 7.1. Introduction
  • 7.2. Auto-Injectors
    • 7.2.1. Disposable Auto-Injectors
    • 7.2.2. Electronic Reusable Auto-Injectors
    • 7.2.3. Mechanical Reusable Auto-Injectors
  • 7.3. Infusion Pumps
    • 7.3.1. Elastomeric Pumps
    • 7.3.2. Syringe Pumps
    • 7.3.3. Volumetric Pumps
      • 7.3.3.1. Ambulatory Volumetric Pumps
      • 7.3.3.2. Floor-Mounted Volumetric Pumps
  • 7.4. Jet Injectors
  • 7.5. Needle-Free Injectors
    • 7.5.1. Liquid Injectors
    • 7.5.2. Powder Injectors
  • 7.6. Pen Injectors
    • 7.6.1. Disposable Pen Injectors
    • 7.6.2. Reusable Pen Injectors
      • 7.6.2.1. Electronic Reusable Pen Injectors
      • 7.6.2.2. Mechanical Reusable Pen Injectors
  • 7.7. Prefilled Syringes

8. Vaccine Delivery Devices Market, by Administration Route

  • 8.1. Introduction
  • 8.2. Intradermal Injection
  • 8.3. Intramuscular Injection
  • 8.4. Intravenous Injection
  • 8.5. Mucosal Delivery
    • 8.5.1. Nasal Delivery
    • 8.5.2. Oral Delivery
  • 8.6. Subcutaneous Injection

9. Vaccine Delivery Devices Market, by Technology

  • 9.1. Introduction
  • 9.2. Conventional Injection Technology
  • 9.3. Needle-Free Technology
  • 9.4. Microneedle Technology
  • 9.5. Smart Delivery Technology
  • 9.6. Controlled Release Technology
  • 9.7. Thermal Stabilization Technology

10. Vaccine Delivery Devices Market, by Vaccine Type

  • 10.1. Introduction
  • 10.2. Live Attenuated Vaccines
  • 10.3. Inactivated Vaccines
  • 10.4. Subunit Vaccines
  • 10.5. mRNA Vaccines
  • 10.6. DNA Vaccines
  • 10.7. Viral Vector Vaccines

11. Vaccine Delivery Devices Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Care Centers
  • 11.3. Clinics
    • 11.3.1. Primary Care Clinics
    • 11.3.2. Specialty Clinics
  • 11.4. Home Healthcare
  • 11.5. Hospitals

12. Vaccine Delivery Devices Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. Europe
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Africa
  • 12.6. Middle East

13. Vaccine Delivery Devices Market, by Group

  • 13.1. NATO
  • 13.2. G7
  • 13.3. BRICS
  • 13.4. European Union
  • 13.5. ASEAN
  • 13.6. GCC

14. Vaccine Delivery Devices Market, by Country

  • 14.1. China
  • 14.2. United States
  • 14.3. Japan
  • 14.4. India
  • 14.5. Germany
  • 14.6. United Kingdom
  • 14.7. Australia
  • 14.8. France
  • 14.9. South Korea
  • 14.10. Italy
  • 14.11. Canada
  • 14.12. Russia
  • 14.13. Brazil
  • 14.14. Mexico
  • 14.15. Spain

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. 3M Company
  • 16.2. ApiJect Systems Corp.
  • 16.3. AptarGroup, Inc.
  • 16.4. B. Braun SE
  • 16.5. Baxter International Inc.
  • 16.6. Becton, Dickinson and Company
  • 16.7. Catalent, Inc.
  • 16.8. Credence MedSystems, Inc.
  • 16.9. Crossject SA
  • 16.10. Gerresheimer AG
  • 16.11. Inovio Pharmaceuticals, Inc.
  • 16.12. Micron Biomedical, Inc.
  • 16.13. NanoPass Technologies Ltd.
  • 16.14. Nemera Development S.A.
  • 16.15. Nipro Corporation
  • 16.16. Owen Mumford Ltd.
  • 16.17. PharmaJet, Inc.
  • 16.18. Portal Instruments, Inc.
  • 16.19. Precision NanoSystems Inc.
  • 16.20. SCHOTT Pharma AG & Co. KGaA
  • 16.21. SHL Medical AG
  • 16.22. Smiths Group plc
  • 16.23. Stevanato Group S.p.A.
  • 16.24. Terumo Corporation
  • 16.25. Unilife Corporation
  • 16.26. Valeritas Holdings, Inc
  • 16.27. Vaxxas Pty Ltd
  • 16.28. Vetter Pharma-Fertigung GmbH & Co. KG
  • 16.29. West Pharmaceutical Services, Inc.
  • 16.30. Ypsomed Holding AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL VACCINE DELIVERY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VACCINE DELIVERY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VACCINE DELIVERY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VACCINE DELIVERY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VACCINE DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL VACCINE DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL VACCINE DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AUTO-INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DISPOSABLE AUTO-INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DISPOSABLE AUTO-INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DISPOSABLE AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ELECTRONIC REUSABLE AUTO-INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ELECTRONIC REUSABLE AUTO-INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ELECTRONIC REUSABLE AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MECHANICAL REUSABLE AUTO-INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MECHANICAL REUSABLE AUTO-INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MECHANICAL REUSABLE AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INFUSION PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INFUSION PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ELASTOMERIC PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ELASTOMERIC PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ELASTOMERIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SYRINGE PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SYRINGE PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SYRINGE PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VOLUMETRIC PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VOLUMETRIC PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VOLUMETRIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AMBULATORY VOLUMETRIC PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AMBULATORY VOLUMETRIC PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AMBULATORY VOLUMETRIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLOOR-MOUNTED VOLUMETRIC PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FLOOR-MOUNTED VOLUMETRIC PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLOOR-MOUNTED VOLUMETRIC PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL JET INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL JET INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL JET INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEEDLE-FREE INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LIQUID INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LIQUID INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LIQUID INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POWDER INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POWDER INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POWDER INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PEN INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PEN INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PEN INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DISPOSABLE PEN INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DISPOSABLE PEN INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DISPOSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL REUSABLE PEN INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL REUSABLE PEN INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL REUSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ELECTRONIC REUSABLE PEN INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ELECTRONIC REUSABLE PEN INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ELECTRONIC REUSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MECHANICAL REUSABLE PEN INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MECHANICAL REUSABLE PEN INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MECHANICAL REUSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRADERMAL INJECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTRADERMAL INJECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRADERMAL INJECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTRAMUSCULAR INJECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAMUSCULAR INJECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTRAMUSCULAR INJECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVENOUS INJECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVENOUS INJECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVENOUS INJECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MUCOSAL DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MUCOSAL DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MUCOSAL DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NASAL DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NASAL DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NASAL DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ORAL DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ORAL DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ORAL DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SUBCUTANEOUS INJECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SUBCUTANEOUS INJECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SUBCUTANEOUS INJECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONVENTIONAL INJECTION TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CONVENTIONAL INJECTION TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CONVENTIONAL INJECTION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NEEDLE-FREE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEEDLE-FREE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEEDLE-FREE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MICRONEEDLE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MICRONEEDLE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MICRONEEDLE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SMART DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SMART DELIVERY TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SMART DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CONTROLLED RELEASE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CONTROLLED RELEASE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONTROLLED RELEASE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL THERMAL STABILIZATION TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL THERMAL STABILIZATION TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL THERMAL STABILIZATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MRNA VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MRNA VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MRNA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DNA VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DNA VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DNA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL VIRAL VECTOR VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL VIRAL VECTOR VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL VIRAL VECTOR VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PRIMARY CARE CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PRIMARY CARE CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PRIMARY CARE CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HOME HEALTHCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HOME HEALTHCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 230. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 233. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 234. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 235. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 236. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 237. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. NATO VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 243. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 244. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 246. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 247. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 249. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 251. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 253. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. G7 VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 292. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 293. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 294. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 295. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 296. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. ASEAN VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 299. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 300. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 302. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 303. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 304. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 305. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 306. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 307. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 308. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 309. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 310. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. GCC VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 313. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 314. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 315. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 317. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 319. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY REUSABLE PEN INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY MUCOSAL DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 342. JAPAN VACCINE DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 343. JAPAN VACCINE DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 344. JAPAN VACCINE DELIVERY DEVICES MARKET SIZE, BY AUTO-INJECTORS, 2018-2032 (USD MILLION)
  • TABLE 345. JAPAN VACCINE DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 346. JAPAN VACCINE DELIVERY DEVICES MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD M